Results 141 to 150 of about 305,335 (274)

The "problem" of predatory publishing remains a relatively small one and should not be allowed to defame open access [PDF]

, 2018
Tom Olijhoek, Jonathan Tennant
openalex  

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Economic and geographical disparities in global contribution to open access publishing in anaesthesiology: A bibliometric analysis. [PDF]

Indian J Anaesth
Slawka E, Guerra-Londono JJ, Hicklen RS, Solanki SL, Cukierman D, Tian J, Cata JP.   +6 more
europepmc   +1 more source

Re: Jena R, Sharma AP, Madhavan K, Sridhar AN, Parmar K, Shrivastava N. What should urologists know about pseudojournals and open access publishing? A narrative review of the literature. Indian J Urol 2022;38:184-90. [PDF]

Indian J Urol, 2023
Kumar N, Tillu ND, Jain S.
europepmc   +1 more source

David among Goliaths: Open access publishing in scientific (semi‐)periphery

, 2020
Bojan Macan, Lea Škorić, Jelka Petrak
openalex   +2 more sources

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

Molecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto, Nicolò Gualandi, Ylenia Cortolezzis, Raffaella Picco, Monica Colitti, Francesca D'Este, Mariachiara Gani, Wayne W. Hancock, Giovanni Terrosu, Cristina Degrassi, Francesca Agostini, Claudio Brancolini, Luigi E. Xodo, Eros Di Giorgio   +13 more
wiley   +1 more source

Editorial: on open access publishing

Suomen Antropologi, 2018
Andrew Graan, Elina Hartikainen, Timo Kallinen, Ville Laakkonen, Tuomas Tammisto, Pekka Tuominen, Matti Eräsaari   +6 more
doaj   +1 more source

Looking back at 20 years of Open Access publishing at Nucleic Acids Research. [PDF]

Nucleic Acids Res
Roberts R.
europepmc   +1 more source

Author Reply Re: Jena R, Sharma AP, Madhavan K, Sridhar AN, Parmar K, Shrivastava N. What should urologists know about pseudojournals and open access publishing? A narrative review of the literature. Indian J Urol 2022;38:184-90. [PDF]

Indian J Urol, 2023
Jena R, Sharma AP, Madhavan K.
europepmc   +1 more source

#OpenAccess: Free online, open-access crowdsource-reviewed publishing is the future; traditional peer-reviewed journals are on the way out [PDF]

, 2019
John R. Adler, Teresa M. Chan, J. Bruce Blain, Brent Thoma, Paul Atkinson   +4 more
openalex   +1 more source